Trial Profile
A Randomized, Single-Blind Pilot Study to Compare the Efficacy and Cost-Effectiveness of Frovatriptan vs. Topiramate for the Prevention of Migraine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jan 2012
Price :
$35
*
At a glance
- Drugs Frovatriptan (Primary) ; Topiramate
- Indications Migraine
- Focus Therapeutic Use
- 21 Dec 2011 Results published in the Headache.
- 07 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Sep 2010 Planned end date changed from 1 Sep 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.